226 related articles for article (PubMed ID: 26476230)
41. Psoriatic arthritis.
Wollina U; Unger L; Heinig B; Kittner T
Dermatol Ther; 2010; 23(2):123-36. PubMed ID: 20415819
[TBL] [Abstract][Full Text] [Related]
42. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
Gottlieb A; Korman NJ; Gordon KB; Feldman SR; Lebwohl M; Koo JY; Van Voorhees AS; Elmets CA; Leonardi CL; Beutner KR; Bhushan R; Menter A
J Am Acad Dermatol; 2008 May; 58(5):851-64. PubMed ID: 18423261
[TBL] [Abstract][Full Text] [Related]
43. Clinical remission of psoriatic arthritis in patients receiving continuous biological therapies for 1 year: the experience of an outpatient dermatological clinic for psoriasis.
Graceffa D; Maiani E; Sperduti I; Ceralli F; Bonifati C
Clin Exp Dermatol; 2015 Mar; 40(2):136-41. PubMed ID: 25438647
[TBL] [Abstract][Full Text] [Related]
44. Early psoriatic arthritis.
Gladman DD
Rheum Dis Clin North Am; 2012 May; 38(2):373-86. PubMed ID: 22819090
[TBL] [Abstract][Full Text] [Related]
45. Refractory Psoriatic Arthritis and Polyarteritis Nodosa: Co-occurrence in a Patient with Undiagnosed HIV.
Awan S; Mandhadi R; Abeles AM
Conn Med; 2017 May; 81(5):285-289. PubMed ID: 29738130
[TBL] [Abstract][Full Text] [Related]
46. Psoriatic arthritis: is it time to treat-to-target or target to treat?
Lubrano E; Perrotta FM
Clin Rheumatol; 2017 Dec; 36(12):2633-2635. PubMed ID: 29067586
[TBL] [Abstract][Full Text] [Related]
47. Psoriatic arthritis.
Day MS; Nam D; Goodman S; Su EP; Figgie M
J Am Acad Orthop Surg; 2012 Jan; 20(1):28-37. PubMed ID: 22207516
[TBL] [Abstract][Full Text] [Related]
48. Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe.
Gottlieb A; Gratacos J; Dikranian A; van Tubergen A; Fallon L; Emir B; Aikman L; Smith T; Chen L
Rheumatol Int; 2019 Jan; 39(1):121-130. PubMed ID: 30426237
[TBL] [Abstract][Full Text] [Related]
49. Resistant cases of psoriatic arthritis: how to manage them.
Atzeni F; Sarzi-Puttini P; Vena GA
J Rheumatol Suppl; 2009 Aug; 83():73-5. PubMed ID: 19661549
[TBL] [Abstract][Full Text] [Related]
50. Updated guidelines for the management of axial disease in psoriatic arthritis.
Nash P; Lubrano E; Cauli A; Taylor WJ; Olivieri I; Gladman DD
J Rheumatol; 2014 Nov; 41(11):2286-9. PubMed ID: 25362712
[TBL] [Abstract][Full Text] [Related]
51. Hemostatic and fibrinolytic changes are related to inflammatory conditions in patients with psoriatic arthritis--effect of different treatments.
Di Minno MN; Iervolino S; Peluso R; Di Minno A; Ambrosino P; Scarpa R;
J Rheumatol; 2014 Apr; 41(4):714-22. PubMed ID: 24532831
[TBL] [Abstract][Full Text] [Related]
52. Outcome Measures in Psoriatic Arthritis.
Coates L
Rheum Dis Clin North Am; 2015 Nov; 41(4):699-710. PubMed ID: 26476227
[TBL] [Abstract][Full Text] [Related]
53. Anti-TNFα discontinuation in rheumatoid and psoriatic arthritis: is it possible after disease remission?
Chimenti MS; Graceffa D; Perricone R
Autoimmun Rev; 2011 Aug; 10(10):636-40. PubMed ID: 21536151
[TBL] [Abstract][Full Text] [Related]
54. Ultrasound-integrated tight control in early psoriatic arthritis during adalimumab treatment.
Bandinelli F; Bonacci E; Matucci-Cerinic M
Clin Exp Rheumatol; 2013; 31(3):440-2. PubMed ID: 23582466
[TBL] [Abstract][Full Text] [Related]
55. Discovery and confirmation of a protein biomarker panel with potential to predict response to biological therapy in psoriatic arthritis.
Ademowo OS; Hernandez B; Collins E; Rooney C; Fearon U; van Kuijk AW; Tak PP; Gerlag DM; FitzGerald O; Pennington SR
Ann Rheum Dis; 2016 Jan; 75(1):234-41. PubMed ID: 25187158
[TBL] [Abstract][Full Text] [Related]
56. [The role of biological agents in the treatment of psoriatic arthritis, literature review].
Koó E; Brodszky V; Péntek M; Ujfalussy I; Nagy MB; Gulácsi L
Orv Hetil; 2006 Oct; 147(41):1963-70. PubMed ID: 17120686
[TBL] [Abstract][Full Text] [Related]
57. Elevated C-Reactive Protein Level Predicts Earlier Treatment with Tumor Necrosis Factor-Alpha Inhibitors in Psoriatic Arthritis.
Ofer-Shiber S; Molad Y
Isr Med Assoc J; 2016 May; 18(5):279-82. PubMed ID: 27430084
[TBL] [Abstract][Full Text] [Related]
58. Treat to target in psoriatic arthritis-evidence, target, research agenda.
Coates LC; Helliwell PS
Curr Rheumatol Rep; 2015 Jun; 17(6):517. PubMed ID: 25903668
[TBL] [Abstract][Full Text] [Related]
59. Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment.
Paramarta JE; De Rycke L; Ambarus CA; Tak PP; Baeten D
Rheumatology (Oxford); 2013 Oct; 52(10):1873-8. PubMed ID: 23861532
[TBL] [Abstract][Full Text] [Related]
60. Psoriatic arthritis treatment and the risk of herpes zoster.
Zisman D; Bitterman H; Shalom G; Feldhamer I; Comanesther D; Batat E; Greenberg-Dotan S; Cohen S; Cohen AD
Ann Rheum Dis; 2016 Jan; 75(1):131-5. PubMed ID: 25261573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
